Literature DB >> 20536523

Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.

D Elleri1, J M Allen, M Nodale, M E Wilinska, C L Acerini, D B Dunger, R Hovorka.   

Abstract

AIMS: We assessed an extended interruption of subcutaneous insulin delivery during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes (T1D).
METHODS: In seven young subjects with T1D [age 14.2+/-2.1 years, diabetes duration 6.9+/-4.0 years, glycated haemoglobin (HbA1c) 8.0+/-1.5%, body mass index (BMI) 21.4+/-4.0 kg/m2, total daily insulin dose 0.9+/-0.2 units/kg/day; mean+/-sd) participating in overnight closed-loop glucose control studies, insulin delivery was interrupted for at least 90 min on the basis of predicted hypoglycaemia, low prevailing glucose levels or a too-steep decline in glucose levels.
RESULTS: Insulin delivery was interrupted for 165 (105, 210) min [median, interquartile range (IQR)]. Plasma glucose was 6.2+/-3.2 mmol/l at the time of interruption and 5.5+/-2.0 mmol/l 105 min later (P=0.15, paired t-test). Plasma glucose declined during the first hour of the interruption at a rate of 0.02+/-0.03 mmol/l per min and reached a nadir of 5.2+/-2.7 mmol/l; 105 min after the interruption, plasma glucose was increasing at a rate of 0.01+/-0.03 mmol/l per min. When insulin delivery restarted, plasma glucose was 6.4+/-2.2 mmol/l and peaked at 7.9+/-2.1 mmol/l in 60 min (P=0.01). Physiological levels of plasma insulin were measured throughout with a nadir of 119+/-78 pmol/l.
CONCLUSIONS: A prolonged interruption of insulin delivery during overnight closed-loop glucose control to prevent hypoglycaemia was not associated with an increased risk of hyperglycaemia in young people with T1D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536523     DOI: 10.1111/j.1464-5491.2010.02964.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

Review 1.  Clinical requirements for closed-loop control systems.

Authors:  William L Clarke; Eric Renard
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control.

Authors:  Justin J Lee; Eyal Dassau; Howard Zisser; Rebecca A Harvey; Lois Jovanovič; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

3.  Feasibility of overnight closed-loop control based on hourly blood glucose measurements.

Authors:  Caroline Patte; Stefan Pleus; Paul Galley; Stefan Weinert; Cornelia Haug; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

4.  Meal Detection in Patients With Type 1 Diabetes: A New Module for the Multivariable Adaptive Artificial Pancreas Control System.

Authors:  Kamuran Turksoy; Sediqeh Samadi; Jianyuan Feng; Elizabeth Littlejohn; Laurie Quinn; Ali Cinar
Journal:  IEEE J Biomed Health Inform       Date:  2015-06-16       Impact factor: 5.772

Review 5.  Closed-loop insulin delivery: from bench to clinical practice.

Authors:  Roman Hovorka
Journal:  Nat Rev Endocrinol       Date:  2011-02-22       Impact factor: 43.330

6.  An integrated multivariable artificial pancreas control system.

Authors:  Kamuran Turksoy; Lauretta T Quinn; Elizabeth Littlejohn; Ali Cinar
Journal:  J Diabetes Sci Technol       Date:  2014-04-07

7.  Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.

Authors:  B Wayne Bequette
Journal:  Annu Rev Control       Date:  2012-12       Impact factor: 6.091

Review 8.  Type 1 diabetes mellitus management in young children: implementation of current technologies.

Authors:  Michal Nevo-Shenker; Moshe Phillip; Revital Nimri; Shlomit Shalitin
Journal:  Pediatr Res       Date:  2019-11-12       Impact factor: 3.756

Review 9.  Closed-loop insulin delivery in type 1 diabetes.

Authors:  Hood Thabit; Roman Hovorka
Journal:  Endocrinol Metab Clin North Am       Date:  2012-03       Impact factor: 4.741

10.  Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.

Authors:  Roman Hovorka; Kavita Kumareswaran; Julie Harris; Janet M Allen; Daniela Elleri; Dongyuan Xing; Craig Kollman; Marianna Nodale; Helen R Murphy; David B Dunger; Stephanie A Amiel; Simon R Heller; Malgorzata E Wilinska; Mark L Evans
Journal:  BMJ       Date:  2011-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.